# Sex-specific hypothalamic PVN transcriptomic signatures of blood pressure autonomic regulation and neuroinflammation in hypertension

**Authors:** V. J. Duque, J. V. Nani, M. Jovanovic, M. Lozić, O. Šarenac, A. G. Pauža, D. M. Murphy, N. Z. Japundžić-Žigon, A. S. Mecawi

PMC · DOI: 10.1186/s13293-026-00855-3 · 2026-02-21

## TL;DR

This study finds that male and female rats with high blood pressure have different brain gene patterns that may explain sex differences in hypertension.

## Contribution

The study identifies sex-specific molecular pathways in the hypothalamus linked to hypertension and autonomic regulation.

## Key findings

- Male hypertensive rats showed more differentially expressed genes and upregulated Bdnf and Agtr1a, linked to elevated blood pressure.
- Female hypertensive rats exhibited anti-inflammatory gene profiles, including upregulated Nlrc3 and Pirb.
- Both sexes shared neuroinflammation-related gene changes, such as downregulated Anxa1 and upregulated Slc11a1.

## Abstract

Hypertension is a multifactorial condition of unknown cause that affects more than 1.28 billion adults worldwide and impacts the sexes differently. The hypothalamic paraventricular nucleus (PVN) plays a central role in blood pressure (BP) regulation by modulating sympathetic tone and releasing neuropeptides that affect the cardiovascular function. In this study, we investigated the transcriptomic profile of the PVN in hypertensive strains and across sexes, aiming to identify novel sex-specific molecular pathways involved in the regulation of BP.

To accomplish this goal, we sequenced RNA from the PVNs of normotensive Wistar rats and Spontaneously Hypertensive Rats (SHR), both male and female. We also performed a cardiovascular assessment based on blood pressure (BP) measurements and their variability.

Cardiovascular assessment revealed higher SBP in SHRs than in Wistar rats; while males exhibited greater autonomic regulation associated with vasomotor and neurohumoral mechanisms, while females maintained comparable SBP levels primarily through an increase in heart rate, reflecting distinct autonomic adaptations. Hypertension also impacted gene expression, with influences from both the hypertensive state and sex. Compared with female SHRs, male SHRs presented a marked increase in differentially expressed genes (DEGs). Key upregulated genes in males, including Brain-Derived Neurotrophic Factor (Bdnf) and Hypocretin (Hcrt), have already been linked to elevated BP, and Angiotensin II Receptor Type 1 (Agtr1a) is possibly associated with increased SBP-VLF variability, which serves as an indirect measure of enhanced sympathetic tone. In contrast, the female transcriptomic signature was characterized by the upregulation of anti-inflammatory pathways, with upregulation of NLR Family CARD Domain Containing 3 (Nlrc3) and Paired Ig-like Receptor B (Pirb), and downregulation of Absent in Melanoma 2 (Aim2), and S100 Calcium Binding Protein B (S100b). Notably, genes associated with neuroinflammation, such as the downregulation of Annexin A1 (Anxa1) and the upregulation of Solute Carrier Family 11 Member 1 (Slc11a1), were consistently altered in both sexes.

These results provide new insights into the cardiovascular and molecular basis of sex differences in hypertension, suggesting distinct neurohumoral autonomic profile in males, whereas in females a greater anti-inflammatory component. These findings offer a valuable framework for developing future sex-specific therapeutic strategies.

The online version contains supplementary material available at 10.1186/s13293-026-00855-3.

Hypertension is a complex condition of unknown cause that affects more than 1.28 billion adults worldwide and impacts the sexes differently. The hypothalamic paraventricular nucleus plays a central role in blood pressure regulation by modulating sympathetic tone and releasing neuropeptides that affect blood pressure. In this study, we investigated the gene expression profile of the PVN in male and female Wistar rats and in Spontaneously Hypertensive Rats to identify the mechanisms involved in the regulation of blood pressure. RNA-sequencing analysis revealed that distinct gene expression profiles were influenced by sex and hypertensive conditions. We demonstrated that hypertensive male rats presented an increased number of differentially expressed genes, indicating a greater impact of hypertension on the paraventricular nucleus in males. The key upregulated genes in males include those previously linked in the literature to elevated blood pressure. In contrast, the female transcriptome was characterized by the upregulation of anti-inflammatory genes, which may mitigate brain inflammation in the paraventricular nucleus, potentially offsetting hypertensive mechanisms. Notably, genes associated with neuroinflammation were identified and found to be conserved between sexes. In conclusion, our data provide new insights into the key mechanisms underlying hypertension, as well as the sex differences of this condition. We demonstrated anti-inflammatory effects in females, which may help explain the lower prevalence of hypertension during the premenopausal period. These results offer a valuable framework for understanding the pathophysiology of hypertension and for developing future sex-specific therapeutic strategies.

The online version contains supplementary material available at 10.1186/s13293-026-00855-3.

Cardiovascular assessment confirmed elevated blood pressure in SHRs compared with Wistar rats, with male SHRs exhibiting a more pronounced vasomotor/neurohumoral autonomic profile than females, whereas females demonstrated a higher heart rate.Transcriptomic profiling of the PVN revealed a greater number of differentially expressed genes in male SHRs, underscoring the impact of hypertension in males.Consistent downregulation of Anxa1 and upregulation of Slc11a1 across both sexes highlights a potential shared mechanism of neuroinflammation in hypertensive states.Key upregulated genes in male SHRs, including Bdnf and Agtr1a, may increases the baseline BP and enhance the VLF component of BP variability as a central feature of the male transcriptomic profile.Compared with male SHRs, female SHRs exhibited an anti-inflammatory signature characterized by upregulation of Nlrc3 and Pirb and downregulation of Aim2, and S100b, which contrasts with the pro-inflammatory state observed in males.

Cardiovascular assessment confirmed elevated blood pressure in SHRs compared with Wistar rats, with male SHRs exhibiting a more pronounced vasomotor/neurohumoral autonomic profile than females, whereas females demonstrated a higher heart rate.

Transcriptomic profiling of the PVN revealed a greater number of differentially expressed genes in male SHRs, underscoring the impact of hypertension in males.

Consistent downregulation of Anxa1 and upregulation of Slc11a1 across both sexes highlights a potential shared mechanism of neuroinflammation in hypertensive states.

Key upregulated genes in male SHRs, including Bdnf and Agtr1a, may increases the baseline BP and enhance the VLF component of BP variability as a central feature of the male transcriptomic profile.

Compared with male SHRs, female SHRs exhibited an anti-inflammatory signature characterized by upregulation of Nlrc3 and Pirb and downregulation of Aim2, and S100b, which contrasts with the pro-inflammatory state observed in males.

The online version contains supplementary material available at 10.1186/s13293-026-00855-3.

## Linked entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627], HCRT (hypocretin neuropeptide precursor) [NCBI Gene 3060], Agtr1a (angiotensin II receptor, type 1a) [NCBI Gene 11607], NLRC3 (NLR family CARD domain containing 3) [NCBI Gene 197358], LILRB1 (leukocyte immunoglobulin like receptor B1) [NCBI Gene 10859], AIM2 (absent in melanoma 2) [NCBI Gene 9447], S100B (S100 calcium binding protein B) [NCBI Gene 6285], ANXA1 (annexin A1) [NCBI Gene 301], SLC11A1 (solute carrier family 11 member 1) [NCBI Gene 6556]

## Full-text entities

- **Genes:** OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}, Anxa1 (annexin A1) [NCBI Gene 25380] {aka Anx1, p35}, Ddx3 (DEAD-box helicase 3) [NCBI Gene 364073] {aka Ddx3yl, RGD1309586}, Agt (angiotensinogen) [NCBI Gene 24179] {aka ANRT, Ang, AngII, PAT}, Aim2 (absent in melanoma 2) [NCBI Gene 304987], Eif2s3 (eukaryotic translation initiation factor 2 subunit gamma) [NCBI Gene 299027] {aka Eif2g, Eif2s3x, PP42}, SLC11A1 (solute carrier family 11 member 1) [NCBI Gene 6556] {aka LSH, NRAMP, NRAMP1}, Lilrb2 (leukocyte immunoglobulin like receptor B2) [NCBI Gene 65146] {aka Lilrb3, NILR-1, Nilr1, Pirb}, NR3C2 (nuclear receptor subfamily 3 group C member 2) [NCBI Gene 4306] {aka MCR, MLR, MR, NR3C2VIT}, Tas2r134 (taste receptor, type 2, member 134) [NCBI Gene 295589] {aka GPCR, T2R134, T2R23, T2R34}, AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 291327], AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185] {aka AG2S, AGTR1B, AT1, AT1AR, AT1B, AT1BR}, Ddx3x (DEAD-box helicase 3, X-linked) [NCBI Gene 317335], RGS2 (regulator of G protein signaling 2) [NCBI Gene 5997] {aka G0S8}, IFI27 (interferon alpha inducible protein 27) [NCBI Gene 3429] {aka FAM14D, ISG12, ISG12A, P27}, Agtr1b (angiotensin II receptor, type 1b) [NCBI Gene 81638] {aka AT1, AT1B, AT3, AT<sub>1</sub>R, Agtr1}, HCRT (hypocretin neuropeptide precursor) [NCBI Gene 3060] {aka NRCLP1, OX, PPOX}, AVPR1A (arginine vasopressin receptor 1A) [NCBI Gene 552] {aka AVPR V1a, AVPR1, V1aR}, Uty (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked) [NCBI Gene 100310845] {aka Kdm6a, RGD1565481, Utx}, E2f2 (E2F transcription factor 2) [NCBI Gene 684111], S100b (S100 calcium binding protein B) [NCBI Gene 25742] {aka S100P}, Kdm5d (lysine demethylase 5D) [NCBI Gene 100312983] {aka Jarid1d}, Hcrt (hypocretin neuropeptide precursor) [NCBI Gene 25723] {aka orexin-A}, LILRB3 (leukocyte immunoglobulin like receptor B3) [NCBI Gene 11025] {aka CD85A, HL9, ILT-5, ILT5, LIR-3, LIR3}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, SYDE2 (synapse defective Rho GTPase homolog 2) [NCBI Gene 84144], Amy1 (amylase alpha 1) [NCBI Gene 24203] {aka Amy1a}, ADRA2A (adrenoceptor alpha 2A) [NCBI Gene 150] {aka ADRA2, ADRA2R, ADRAR, ALPHA2AAR, FPLD8}, Nlrc3 (NLR family, CARD domain containing 3) [NCBI Gene 287070] {aka Nlrc3-ps1, RGD1304902}, Ackr3 (atypical chemokine receptor 3) [NCBI Gene 84348] {aka Cmkor1, Cxcr7, Rdc1}, Ace (angiotensin I converting enzyme) [NCBI Gene 24310] {aka CD143, Dcp1, StsRR92}, Slc11a1 (solute carrier family 11 member 1) [NCBI Gene 316519] {aka Bcg, Itg, Lsh, Nramp1}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, ESR2 (estrogen receptor 2) [NCBI Gene 2100] {aka ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2}, Agtr1a (angiotensin II receptor, type 1a) [NCBI Gene 24180] {aka AT1, AT1A, AT1R, Agtr1}, Tnfrsf12a (TNF receptor superfamily member 12A) [NCBI Gene 302965] {aka Fn14}, MRGPRX4 (MAS related GPR family member X4) [NCBI Gene 117196] {aka GPCR, MRGX4, SNSR6}, S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}, TNFRSF12A (TNF receptor superfamily member 12A) [NCBI Gene 51330] {aka CD266, FN14, TWEAKR}, Esr2 (estrogen receptor 2) [NCBI Gene 25149] {aka ER-beta, ERbeta, Erb2}, Aqp4 (aquaporin 4) [NCBI Gene 25293] {aka AQP-4, Miwc, WCH4}, Zap70 (zeta chain of T cell receptor associated protein kinase 70) [NCBI Gene 301348] {aka Srk}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Pbdc1 (polysaccharide biosynthesis domain containing 1) [NCBI Gene 363485] {aka RGD1562502}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, Sgk1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 29517] {aka Sgk}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, Esr1 (estrogen receptor 1) [NCBI Gene 24890] {aka ER-alpha, Esr, RNESTROR}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, Arxes2 (adipocyte-related X-chromosome expressed sequence 2) [NCBI Gene 100360464], Ddx3y (DEAD box helicase 3, Y-linked) [NCBI Gene 100312982] {aka Ddx3}, Syde2 (synapse defective Rho GTPase homolog 2) [NCBI Gene 308021] {aka RGD1564206, Syde2-ps1}, AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, NLRC3 (NLR family CARD domain containing 3) [NCBI Gene 197358] {aka CLR16.2, NOD3}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Avp (arginine vasopressin) [NCBI Gene 24221] {aka ADH, DI, VP, Vas}
- **Diseases:** BP (MESH:D006973), elevated blood (MESH:D006402), CVD (MESH:D002318), myocardial infarction (MESH:D009203), atrial fibrillation (MESH:D001281), bacterial infection (MESH:D001424), heart failure (MESH:D006333), pain (MESH:D010146), inflammation (MESH:D007249), neurodegeneration (MESH:D019636), neuroinflammation (MESH:D000090862), DM (MESH:D009223), stroke (MESH:D020521), hemorrhage (MESH:D006470), HF (MESH:D006316), drop of heart (MESH:D020427)
- **Chemicals:** sodium (MESH:D012964), Guillotine (-), catecholamine (MESH:D002395), salt (MESH:D012492), carprofen (MESH:C007005), xylazine (MESH:D014991), toluidine blue (MESH:D014048), ethanol (MESH:D000431), noradrenaline (MESH:D009638), glutamate (MESH:D018698), gentamicin (MESH:D005839), progesterone (MESH:D011374)
- **Species:** Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Rattus norvegicus (brown rat, species) [taxon 10116], Rattus (rat, genus) [taxon 10114]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964816/full.md

---
Source: https://tomesphere.com/paper/PMC12964816